The rising prevalence in GLP-1 agonists for diabetes has sparked a discussion about delivery routes : skin-applied devices versus pills . Usually , GLP-1 treatments were only available in pill form, but https://haimanowh686872.blogchaat.com/41245164/glp-1-skin-applications-vs-tablets-what-suitable-for-individuals